Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations

Clinical trial NCT02258321 · COMPLETED

Trial details

NCT number: NCT02258321
Sponsor: Presidio Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetic Assessments in Healthy Volunteers

Start date: 2014-10-01
Primary completion: 2014-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.